Androgen depletion up-regulates cadherin-11 expression in prostate cancer

Journal of Pathology

Volumn 221, Issue 1, 2010, Pages 68-76

  Lee, Yu Chen ^a   Cheng, Chien Jui ^c   Huang, Miao ^a   Bilen, Mehmet A ^a   Ye, Xiangcang ^a   Navone, Nora M ^a   Chu, Khoi ^a   Kao, Hsin Hsin ^a   Yu Lee, Li Yuan ^b   Wang, Zhengxin ^a   Lin, Sue Hwa ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Androgen receptor; Bone metastasis; Cadherin 11; Osteoblast; PCa

Indexed keywords

ANDROGEN; CADHERIN; CADHERIN 11; UNCLASSIFIED DRUG;

ANDROGEN DEPRIVATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASTRATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR RECURRENCE; TUMOR VOLUME; UPREGULATION; XENOGRAFT;

ANDROGENS; ANIMALS; CADHERINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; ORCHIECTOMY; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TUMOR CELLS, CULTURED; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77951020901     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2687     Document Type: Article

References (14)

1. Ye XC, Choueiri M, Tu SM, Lin SH. Biology and clinical management of prostate cancer bone metastasis. Front Biosci 2007; 12: 3273-3286.
2. Rosenbaum E, Carducci MA. Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges. Expert Opin Pharmacother 2003; 4: 875-887. (Pubitemid 36722479)
3. Chu K, Cheng C-J, Ye X, Lee Y-C, Zurita AJ, Chen D-T, et al. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 2008; 6: 1259-1267.
4. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, et al. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigenproducing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998; 77: 887-894. (Pubitemid 28378138)
5. Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R, et al. VCaP, a cell-based model system of human prostate cancer. In Vivo 2001; 15: 163-168. (Pubitemid 32328191)
6. Lira CB, Chu K, Lee YC, Hu MC, Lin S-H. Expression of the extracellular domain of OB-cadherin as an Fc fusion protein using bicistronic retroviral expression vector. Protein Expr Purif 2008; 61: 220-226.
7. Park SI, Zhang J, Phillips KA, Araujo JC, Najjar AM, Volgin AY, et al. Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Res 2008; 68: 3323-3333.
8. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996; 2: 1627-1636. (Pubitemid 126447459)
9. Furr BJ, Tucker H. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology 1996; 47(1A suppl): 13-25. (Pubitemid 126691282)
10. Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, et al. Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res 2005; 11: 6823-6834. (Pubitemid 41428737)
11. Cheng CJ, Ye XC, Vakar-Lopez F, Kim J, Tu SM, Chen DT, et al. Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Mol Cancer Res 2007; 5: 675-684. (Pubitemid 47105486)
12. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, Yamamoto KR. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 2007; 21: 2005-2017. (Pubitemid 47267287)
13. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999; 59: 947-952. (Pubitemid 29086753)
14. Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol 2008; 33: 17-24.